Summary & Overview
CPT 95004: Percutaneous Allergen Skin Test
CPT code 95004 represents a percutaneous allergen skin test used to identify substances that provoke IgE-mediated allergic reactions. This diagnostic procedure is commonly performed in outpatient allergy or immunology clinics and informs clinical management for allergic rhinitis, asthma triggers, drug or food sensitivities, and other allergic conditions. Nationally, accurate coding for skin testing is important for care coordination, quality measurement, and appropriate reimbursement for allergy diagnostic services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of CPT code 95004, expected sites of service, and the role of the test in differential diagnosis and treatment planning. The publication outlines common billing considerations, typical modifiers in use, and how payers approach coverage in general terms. It also summarizes relevant benchmarks and policy updates where available. The content is intended to help billing professionals, clinicians, and practice managers understand the clinical context and billing landscape for percutaneous allergen testing on a national scale.
Billing Code Overview
CPT code 95004 describes a percutaneous allergen testing procedure in which a provider applies allergenic extracts to the patient's skin to determine which substances trigger an allergic reaction. The test is used to identify IgE-mediated sensitivities by observing localized skin responses to applied extracts.
Service Type: Diagnostic allergy testing
Typical Site of Service: Outpatient clinic or office-based allergy/immunology setting, including specialty practices where skin testing is performed under medical supervision.
Clinical & Coding Specifications
Clinical Context
A 28-year-old patient presents to an outpatient allergy clinic with a 2-year history of seasonal allergic rhinitis and suspected allergic conjunctivitis unresponsive to avoidance and antihistamines. The clinician reviews history, performs a focused physical exam, and documents suspected triggers (tree pollen, grass, cat dander). After informed consent and screening for contraindications (e.g., uncontrolled asthma, beta-blocker use), the provider performs a percutaneous skin test using standardized allergenic extracts to identify sensitizing allergens. The test consists of placing drops of allergen extracts on the volar forearm or back and introducing the allergen percutaneously via gentle lancet puncture. Positive and negative controls are included. Wheal-and-flare reactions are read at 15–20 minutes and documented in the medical record with size measurements and interpretation. Results guide allergen avoidance counseling and consideration of immunotherapy. Typical workflow includes preprocedure assessment, test administration, timed reading, documentation of results, and postprocedure observation for systemic reactions. Typical site of service is an outpatient clinic or office-based allergy/immunology practice; testing may also occur in ambulatory surgical centers or pediatric clinics when indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service on the same day | When a distinct evaluation and management visit is performed on same day as testing |
26 | Professional component | When reporting only the physician professional component separate from technical component |
TC | Technical component | When reporting only the facility/technical component of the test |
59 | Distinct procedural service | When a different service/procedure is performed at a separate site or distinct session |
76 | Repeat procedure or service by same physician | When the skin test is repeated by same provider during same encounter |
77 | Repeat procedure by another physician | When repeated by a different physician |
91 | Repeat clinical diagnostic laboratory test | When multiple readings are performed and require repeat documented measurements (used sparingly) |
52 | Reduced services | When testing is partially reduced or not completed due to patient intolerance |
53 | Discontinued procedure | When testing is started but discontinued for medical reasons |
95 | Synchronous telemedicine service rendered via real-time interactive audio and video | When remote supervision or interpretation is rendered in real time (limited applicability) |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RH0000X | Allergy & Immunology | Primary specialty that performs percutaneous skin testing |
| 207RC0000X | Pediatrics | Pediatricians experienced in performing skin testing in children |
| 207RI0000X | Otolaryngology (ENT) | ENTs may perform testing as part of allergy evaluation |
| 207RN0400X | Family Medicine | Family medicine physicians commonly perform office-based allergy testing |
| 208D00000X | Dermatology | Dermatologists may perform allergy skin testing for contact and environmental allergens |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
J30.1 | Allergic rhinitis due to pollen | Common indication for skin testing to identify specific pollen sensitization |
J30.2 | Other seasonal allergic rhinitis | Indicates seasonal symptoms prompting testing for seasonal allergens |
J30.3 | Other allergic rhinitis | Broad allergic rhinitis diagnosis where testing clarifies triggers |
J30.9 | Allergic rhinitis, unspecified | Used when allergic rhinitis is present and testing is required to specify allergens |
H10.1 | Acute atopic conjunctivitis | Associated ocular allergy prompting identification of offending allergens |
T78.2XXA | Anaphylactic shock, unspecified, initial encounter | Relevant as a precaution—history of anaphylaxis affects test selection and setting |
L50.9 | Urticaria, unspecified | Chronic or recurrent urticaria may warrant allergy testing as part of evaluation |
Z91.041 | Allergy to peanuts | Example of documented specific allergy; testing may be used to confirm sensitization |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
95024 | Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report | Performed when percutaneous screening (95004) is negative or when more sensitive intradermal testing is indicated |
95027 | Intracutaneous tests for delayed type hypersensitivity, readings at 24–72 hours | Used when delayed hypersensitivity testing (patch or intradermal delayed reading) is clinically indicated following screening |
95165 | Professional services for allergen immunotherapy not including provision of allergenic extracts; single or initial injection | Follows identification of relevant allergens when initiating allergen immunotherapy |
99000 | Handling and/or conveyance of specimen for transfer from patient to laboratory (when applicable) | Occasionally used for associated specimen handling if extracts or materials are processed |
99213 | Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes | Common accompanying E/M service on the same day when 25 modifier is appended if separate and significant |